Your browser doesn't support javascript.
loading
Antibody response after third dose of COVID-19 mRNA vaccination in allogeneic hematopoietic stem cell transplant recipients is comparable to that in healthy counterparts.
Takagi, Erina; Terakura, Seitaro; Fujigaki, Hidetsugu; Okamoto, Akinao; Miyao, Kotaro; Sawa, Masashi; Morishita, Takanobu; Goto, Tatsunori; Ozawa, Yukiyasu; Nishida, Tetsuya; Fukushima, Nobuaki; Ozeki, Kazutaka; Hanajiri, Ryo; Saito, Kuniaki; Murata, Makoto; Tomita, Akihiro; Kiyoi, Hitoshi.
Afiliação
  • Takagi E; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8560, Japan.
  • Terakura S; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8560, Japan. tseit@med.nagoya-u.ac.jp.
  • Fujigaki H; Department of Advanced Diagnostic System Development, Fujita Health University Graduate School of Health Sciences, Toyoake, Japan.
  • Okamoto A; Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan.
  • Miyao K; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
  • Sawa M; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
  • Morishita T; Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan.
  • Goto T; Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan.
  • Ozawa Y; Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan.
  • Nishida T; Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan.
  • Fukushima N; Department of Hematology and Oncology, JA Aichi Konan Kosei Hospital, Konan, Japan.
  • Ozeki K; Department of Hematology and Oncology, JA Aichi Konan Kosei Hospital, Konan, Japan.
  • Hanajiri R; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8560, Japan.
  • Saito K; Department of Advanced Diagnostic System Development, Fujita Health University Graduate School of Health Sciences, Toyoake, Japan.
  • Murata M; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8560, Japan.
  • Tomita A; Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan.
  • Kiyoi H; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8560, Japan.
Int J Hematol ; 118(4): 462-471, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37561340
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / COVID-19 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: Int J Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / COVID-19 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: Int J Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão